Tiotropium bromide is a new quaternary ammonium compound with anticholinergic properties specific for muscarinic receptors (M1, M2, and M3) in humans. [1] Because acetylcholine modulates bronchial ...
Details concerning the Tiotropium Bromide combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...
September 20, 2010 (Barcelona, Spain) — Adding the anticholinergic agent tiotropium bromide (Spiriva, Boehringer-Ingelheim and Pfizer), approved for the treatment of chronic obstructive pulmonary ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved Lupin’s 18 µg capsules of tiotropium bromide inhalation powder, according to a manufacturer ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Please provide your email address to receive an email when new articles are posted on . The use of tiotropium bromide may be beneficial in the treatment of patients with moderate to severe asthma, ...
SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term, once-daily maintenance treatment of bronchospasm associated ...
DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Tiotropium Bromide Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Tiotropium Bromide, developed by ...
Vectura Group plc (LSE: VEC) ("Vectura", "the Group"), an industry-leading device and formulation business for inhaled airways products, today announces it is progressing the development of a branded ...
Research and Markets (http://www.researchandmarkets.com/research/rvchgj/investigation) has announced the addition of the "Investigation Report on China Tiotropium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results